Trials / Unknown
UnknownNCT06019273
Impacts of Different ART Regimens on Lipid Metabolism in People Living With HIV
Impacts of Different ART Regimens on Lipid Metabolism in People Living With Human Immunodeficiency Virus
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
To compare the dynamic changes of lipid metabolism of people living HIV who treated with different antiretroviral therapy (ART) regimens such as Biktarvy EVG/c/TAF/FTC, DTG/FTC/TDF, TDF/3TC/EFV, etc. And to assess the safety and efficacy of different antiretroviral therapy.
Detailed description
This was a prospective observational study aiming to evaluate dynamic changes of lipid metabolism in people living HIV who treated with different antiretroviral therapy (ART) regimens. At the same time, cardiovascular risk and the incidence of non-alcoholic fatty liver disease are assessed so as to compare the effects of different regimen on cardiovascular risk and NAFLD and hope to discover several cardiovascular risk-related individual lipid species.
Conditions
Timeline
- Start date
- 2022-04-25
- Primary completion
- 2024-04-25
- Completion
- 2024-05-01
- First posted
- 2023-08-31
- Last updated
- 2023-09-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06019273. Inclusion in this directory is not an endorsement.